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Abstract
Background: Entomological methods may provide important tools for monitoring the progress
of lymphatic filariasis elimination programs. In this study, we compared dissection of the vector,
Culex quinquefasciatus, with the polymerase chain reaction (PCR) to assess filarial infection levels in
mosquitoes in the context of a lymphatic filariasis elimination program in Leogane, Haiti.
Methods: Mosquitoes were collected using gravid traps located in 4 sentinel communities with
Wuchereria bancrofti microfilaria prevalence that ranged from 0.8% to 15.9%. Captured mosquitoes
were divided between dissection, to enumerate W. bancrofti larvae (L1, L2, L3) and desiccation for
later analysis by PCR. PCR was conducted on DNA extracts from pooled mosquitoes (1–15 pooled
females) utilizing a competitive PCR system with primers specific for the Ssp I repeat. PCR products
were analyzed with a hybridization ELISA using probes specific for a control sequence and the Ssp
I repeat.
Results:  The prevalence of mosquito infection with W. bancrofti ranged from 0%–3.66% by
dissection (L1–L3) and point estimates of infection prevalence, as assayed by PCR, ranged from
0.25% – 9.16%. Following mass treatment, W. bancrofti infection prevalence dropped significantly as
determined by PCR and dissection in 2 of the 4 sentinel sites (Leogane and Barrier Jeudi, P = 0.04
and P = 0.005, respectively). Although transmission declined in the other two sites, larval
recoveries were low and these changes were not statistically significant.
Discussion: Our results suggest that a single round of mass treatment can have an impact on
transmission of lymphatic filariasis. The use of entomologic methods as a tool to monitor filariasis
programs and the statistical limitations of mosquito trapping are discussed.
Background
Nearly 1.2 billion people are at risk of developing lym-
phatic filariasis and over 128 million are estimated to
have circulating microfilariae or one of the various clinical
conditions associated with filarial infection [1]. With
tools currently available, lymphatic filariasis, in principle,
could be eliminated. Combined drug treatment regimens
using annual treatment with microfilaricidal drugs are the
method of choice for combating filarial infection and
Published: 07 July 2003
Filaria Journal 2003, 2:11
Received: 06 March 2003
Accepted: 07 July 2003
This article is available from: http://www.filariajournal.com/content/2/1/11
© 2003 Goodman et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/11
Page 2 of 9
(page number not for citation purposes)
elimination programs using this strategy have com-
menced in more than 30 countries [2].
Demonstrating the success of filariasis programs depends
on careful monitoring of infection levels in human popu-
lations as well as vectors following the introduction of the
drug intervention. Due to reluctance on the part of human
populations to submit to regular blood examinations,
assessment of infection in vectors offers advantages for the
monitoring of infection after a mass treatment program
has been implemented. Two methods of detecting infec-
tion in vector populations that are now being widely used
are dissection and PCR. Dissection has been the gold
standard for measuring infection level in mosquitoes;
however, dissection becomes increasingly costly and labo-
rious in areas where mosquito infection prevalence drops
below 1%. Furthermore, in preliminary studies, PCR was
more sensitive for detecting filarial parasites in mosqui-
toes than conventional dissection and microscopy [3].
The ability to adapt PCR techniques to detect microfilariae
in pools of mosquitoes suggests that current PCR methods
should be adequate for testing large numbers of mosqui-
toes in the context of filariasis elimination programs. PCR
has already been demonstrated to be a successful tool for
monitoring onchocerciasis programs [4,5]. The availabil-
ity of such a tool permits rigorous surveillance for resump-
tion of transmission following completion of control
activities.
This study was designed to monitor mosquito infection
levels in conjunction with a mass treatment program for
filariasis in the commune of Leogane, Haiti. The goal of
this program in Leogane was to develop an effective elim-
ination strategy that could be adapted to other settings in
Haiti and elsewhere. The drug intervention consisted of
annual treatment with diethylcarbamazine (DEC) and
albendazole and was monitored by collecting data in 4
well-characterized sentinel sites. We assessed filarial infec-
tion rates of vectors trapped in the 4 sentinel sites and
compared PCR with dissection as monitoring tools.
Methods
Study site
The study was conducted in the plains of the Commune
of Leogane, located west of Port au Prince. To monitor the
impact of the mass treatment program, sentinel sites were
chosen based on estimated community antigen preva-
lence inferred from rapid card-based immunochromato-
graphic testing (ICT) of local school children (Amrad ICT,
New South Wales, Australia). Microfilaria prevalence and
intensity were assessed in the sentinel sites prior to the
intervention. Mass treatment using single dose diethylcar-
bamazine (6 mg/kg) and albendazole (400 mg) was car-
ried out at the end of October 2000. Details of the drug
distribution will be reported elsewhere. Research activities
in the sentinel sites were reviewed and approved by the
CDC and Notre Dame Institutional Review Boards, and
the Ethics Committee of Hopital St. Croix.
Mosquito Trapping
The main vector for Wuchereria bancrofiti in Haiti is Culex
quinquefasciatus  [6]. Some transmission occurs year-
round. The trapping of mosquitoes was done using CDC
gravid traps (Model 1712, J.W. Hock Co., Gainesville, FL),
5 to 6 per sentinel site. Collections were done in each sen-
tinel site for 4 consecutive nights every other week. Mos-
quitoes were collected from traps each morning within 30
minutes of dawn. After transport to the laboratory at
Hopital St. Croix, mosquitoes were knocked down by
placing trap containers in a -20°C freezer for ten minutes
or by introduction of a triethylamine-soaked cotton pad,
and subsequently separated by species and sex; undesired
specimens were noted and discarded (males and non-vec-
tor species). Female Culex mosquitoes were divided 1:1
for assay by PCR or dissection for the first 100 mosquitoes
caught at each trap; the remainder was used for PCR. The
samples to be used for PCR assay were desiccated and
sorted until shipment to CDC for processing. Because pre-
liminary PCR experiments showed inhibition to be an
occasional problem when pool sizes of 25 or greater were
used, mosquitoes to be desiccated were sorted into
batches of no more than 15 mosquitoes and then placed
atop a cotton plug, which was above 1/4 inch of drierite
desiccant in a polypropylene screw cap tube. This ensured
desiccation and reduced any concerns about fungal con-
tamination during storage and transport.
Mosquito Dissection
Mosquitoes were dissected on a glass slide using a set of
dissection needles to separate the head, thorax, and abdo-
men. A saline solution was dropped onto each segment.
These three body segments were then teased apart and
examined stereoscopically to reveal larval stage worms or
microfilaria. Mosquito infection status was noted as well
as the corresponding location of the parasites. Ten percent
of dissected mosquitoes harboring 3rd stage larvae were
microscopically examined at 100× to verify filarial species.
A maximum of 50 mosquitoes were dissected per trap per
day. Dissection results were entered into an Epi-Info data-
base. Infective mosquitoes were defined as those contain-
ing L3 larvae in any of the body segments. Mosquitoes
carrying microfilaria, L1, L2, or L3 larvae were defined as
infected.
Extraction of DNA
DNA extraction for PCR amplification was performed as
described by Chanteau et al. [7]. Briefly, the dried pools of
mosquitoes were homogenized with a pellet pestle (Kim-
ble/Kontes, Vineland, NJ, USA) and 500 µl of NIB buffer
(5 M NaCl, 1 M Tris pH 8, 0.5 M EDTA, 0.07% β-mercap-Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/11
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toethanol, 0.5% NP-40) in a 1.5 ml eppendorf tube
(Marsh Bio Products, Rochester, NY, USA). The extracted
DNA was then bound to silica beads (Sigma-Aldrich, St.
Louis, MO, USA). The beads were washed to remove
inhibitors. After washing, the silica beads were dried and
the DNA was then eluted into 100 µl of 1X Tris-EDTA (1%
Tris, 0.02% EDTA), pH 8.
PCR Amplification
The PCR for the competitive ELISA analysis was con-
ducted using NV-1 and NV-2 oligonucleotides specific for
the Ssp I repeat as previously described by Bockarie and
others [8]. Amplification was performed with an Applied
Biosystems 9700 PCR thermocycler (Branchburg, NJ,
USA) using 36 cycles with Amplitaq gold (Applied Biosys-
tems Branchburg, NJ, USA) in a reaction volume of 50 µl.
Included in the assays was 100 fg of internal control plas-
mid [9] (generously provided by Dr. Steven Williams of
Smith College) to verify amplification. Primer NV-2 was
biotinylated to facilitate binding of the product to a
streptavidin (Sigma-Aldrich) -coated microtiter plate
(Immulon II Thermo Labsystems, Franklin, MA, USA). UV
treated distilled water without internal control was used
as a negative control. Positive control DNA was derived
from parasites obtained from microfilaria infected indi-
viduals. Filarial DNA was extracted using a DNAzol (Inv-
itrogen, Carlsbad, CA, USA) extraction method as
described by the manufacturer.
PCR-ELISA
PCR products were detected by ELISA as per protocols
described by Fischer and others [9] with slight modifica-
tions described below. PCR product was added to strepta-
vidin-coated plates. The initial volume of the PCR product
(50  µl) was diluted to a total volume of 220 µl with
hybridization buffer. Samples were tested at 100 µl per
well and were hybridized with fluorescein-labeled probes
specific for wild type or internal control sequences. Probes
were hybridized to plate bound PCR products at 55°C for
30 minutes and then incubated alkaline phosphatase-
labelled anti-fluorescein Fab fragments (Roche Diagnos-
tics, Indianapolis, IN). Plates were sealed with Falcon
pressure sensitive film (Falcon Becton Dickinson, Frank-
lin Lakes, NJ, USA) at all assay stages to eliminate any
potential contamination between wells. Plates were read
on a Uvmax plate reader at 405 nm (Molecular Devices,
Sunnyvale, CA, USA) after 1 hr development with sub-
strate. A positive sample was defined as previously
described, as 5 times the uncorrected optical density (OD)
of a sample containing no template DNA, but with 100 fg
of internal control [8]. The controls were designed to
allow for cutoff determination, as well as to determine the
success of the PCR thermocycler run. Amplified high pos-
itive control DNA (0.1 µg of extracted W. bancrofti DNA)
yielded an almost immediate response by ELISA and low
positive control DNA (0.01 µg concentration) provided a
low range positive against which to compare samples.
Both sample positive controls were run with and without
100 fg of internal control to monitor the level of competi-
tion between internal control and W. bancrofti template
DNA. Negative controls included water with and without
100 fg of internal control and DNA extracted from a pool
of 15 parasite-negative lab-reared mosquitoes (2 µl of
extracted product, prepared in parallel with Haitian sam-
ples). UV treated, distilled, deionized water was used to
replace the volume of mosquito DNA usually present.
This sample was run in triplicate, along with all other con-
trols. In conjunction with the PCR controls, the microtiter
plates had a plate blank on each plate that was 6 wells of
sample buffer hybridized with either wild probe or inter-
nal control. Positive controls exhibited a high degree of
reproducibility with the cutoff as established. The high
positive (0.1 µg W. bancrofti DNA) was 97% reproducible
and the low positive was positive for 86% of the assays.
Statistical Analysis
Prevalence rates from dissection data were computed and
compared using Sudaan version 8.0 (SUDAAN Statistical
Software Center, Research Triangle Park, NC, USA), which
takes into consideration the correlation of multiple collec-
tions from the same location over time. The t-test was
used for rate comparisons. The Pearson correlation coeffi-
cient was used to estimate the association of dissection
based prevalence rates with PCR based rates. PCR point
estimates were computed and compared using Poolscreen
2.0 generously provided by Dr. Tom Unnasch and Charles
Katholi (The University of Alabama, Birmingham) [10].
Results
Baseline microfilaria prevalence in the human population
ranged from 0.8–15.9% in the sentinel sites (Table 1).
Median microfilaria level ranged from 5 to 11 microfilaria
per 20 µl for microfilaria-positive persons. Microfilaria
intensity did not differ significantly by sentinel site (Table
1). Mass treatment with DEC/albendazole took place at
the end of October 2000 and tablets were taken by 72% of
the at risk population [11]. By 9 months following treat-
ment, microfilaria prevalence declined to 3%, 4.3%, 0.4%
and 6% in Barrier Jeudi, Masson/Mathieu, Mapou and
Leogane, respectively.
To monitor the impact of mass treatment on filarial infec-
tion level in mosquitoes, trapping was initiated in August
of 2000, 3 months prior to mass treatment. Because the
number of mosquitoes trapped and percentage of infected
mosquitoes varied from month to month, results were
pooled into 3-month intervals for analysis. As seen in Fig-
ure 1, total mosquito infection levels, as detected by dis-
section, declined from pre-treatment to the first post-
treatment interval in all 4 sites; however, these decreasesFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/11
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were statistically significant in only 2 of the sites, Leogane
and Barrier Jeudi. With the exception of Mapou, larval
infection rates were lower in the second than in the first 3-
month time interval following treatment. The numbers of
L3 larvae recovered declined significantly in only one of
the 4 sentinel sites (Figure 1, Table 2). If we adopt a more
conservative definition of what constitutes an infective
mosquito and restrict our analysis to those with L3 found
in the head, no change over time was observed. In fact,
only 16 out of 9459 mosquitoes dissected had L3 in the
head (Table 3).
W. bancrofti infection of Culex  mosquitoes was also
assessed by PCR for a total of 1704 pools (median pool
size = 7) collected over the study period. Because pool
sizes ranged from 1 to 15, we used Poolscreen 2.0 to gen-
erate point estimates and confidence intervals for the level
of filarial infection in mosquitoes. As seen in Table 4,
point estimates of W. bancrofti infection prevalence
declined following mass treatment in all 4-sentinel sites.
Because of the relatively wide confidence intervals, signif-
icant declines in infection prevalence were observed in
only Barrier Jeudi and Leogane for both time periods fol-
lowing treatment, mirroring the results obtained with
dissection.
We also compared changes in infection prevalence for
mosquito pools of constant size (n = 15) collected in the
Leogane sentinel site. The other three sentinel sites did not
have enough pools of this size to conduct this analysis
(Table 4). Infection prevalence in Leogane decreased from
4.5% pre-treatment to 0.55% in the first three months fol-
lowing treatment and to 0.12% in the second time period
(Figure 2). These numbers agree closely with those gener-
ated when all pools were included in the analysis. There
was a moderately strong correlation between larval infec-
tion rates as determined by dissection and PCR (Figure 3;
r = 0.72, p = 0.008).
Discussion
Careful monitoring of filarial transmission is necessary,
both to make programmatic decisions about stopping
mass treatment as well as to assist with certification of
elimination. Serologic tools for assessment of exposure to
Table 1: Wuchereria bancrofti Baseline Microfilaria Prevalence1
Community Microfilaria (%) Median2
Barrier Jeudi 78/1157 (6.7) 8
Masson/ Mathieu 125/1140 (11.0) 11
Mapou 5/588 (0.8) 5
Leogane 98/617 (15.9) 7
1 Microfilaria prevalence was determined by microscopic examination of a stained 20 µl thick film. Blood was collected nocturnally. 2 Median 
microfilaria count per 20 µl for microfilaria-positive persons.
Table 2: W. bancrofti Larval Recoveries in Dissected Mosquitoes Before and After Treatment
Locale Time Interval #Dissected Mosquitoes w/larvae %infected1 Mosquitoes w/L3 %infective
Masson/ 
Mathieu
Aug-Oct 334 7 2.1 (0.85,4.27) 4 1.20 (0.33,3.04)
Masson/ 
Mathieu
Nov-Jan 449 7 1.56 (0.63,3.19) 6 1.34 (0.49, 2.89)
Masson/ 
Mathieu
Feb-April 674 5 0.74 (0.24,1.72) 1 0.14 (0,0.82)
Mapou Aug-Oct 379 2 0.53 (0.06,1.89) 1 0.26 (0.01,1.46)
Mapou Nov-Jan 815 0 0 (0,0.45) 0 0 (0,0.45)
Mapou Feb-April 370 2 0.54 (0.07,1.94) 2 0.54 (0.07,1.94)
Barrier Jeudi Aug-Oct 328 12 3.66 (1.90, 6.30) 8 2.44 (1.06,4.75)
Barrier Jeudi Nov-Jan 722 5 0.69** (0.23,1.61) 0 0* (0,0.51)
Barrier Jeudi Feb-April 902 5 0.55* (0.16,1.17) 2 0.22 (0.03,0.80)
Leogane Aug-Oct 2033 52 2.56 (1.92,3.34) 18 0.89 (0.53,1.40)
Leogane Nov-Jan 1385 22 1.59 (1.00,2.40) 10 0.72 (1.00,2.40)
Leogane Feb-April 1068 16 1.50* (0.86,2.42) 8 0.75 (0.86,2.42)
1Prevalence (95% confidence interval) * = P < 0.05 ** = P < 0.01 Compared to BaselineFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/11
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Wuchereria bancrofti in Culex mosquitoes before and after mass treatment Figure 1
Wuchereria bancrofti in Culex mosquitoes before and after mass treatment. Dissection results were pooled in 3-month intervals 
and are plotted for each of the four sentinel sites. The percentage of mosquitoes harboring any stage larvae is plotted in the 
lighter bars. The percentage of mosquitoes carrying L3 larvae is plotted in the darker bars. Significant changes from the August-
October pre-treatment interval are indicated with an asterisk. Note that different scales are used for each sentinel site.
Table 3: W. bancrofti L3 Stage Larvae Recoveries in Dissected Mosquitoes Before and After Treatment
Locale Time Interval #Dissected #Mosquitoes w/
L3 in Head




Masson/Mathieu Aug-Oct 334 1 0.3 (0.01, 1.66) 4 1.20 (0.33,3.04)
Masson/Mathieu Nov-Jan 449 2 0.45 (0.05, 1.60) 6 1.34 (0.49, 2.89)
Masson/Mathieu Feb-April 205 0 0 (0, 1.78) 1 0.14 (0,0.82)
Mapou Aug-Oct 379 0 0 (0, 0.97) 1 0.26 (0.01,1.46)
Mapou Nov-Jan 815 0 0 (0, 0.45) 0 0 (0,0.45)
Mapou Feb-April 370 1 0.27 (0.01, 1.50) 2 0.54 (0.07,1.94)
Barrier Jeudi Aug-Oct 328 4 1.22 (0.33, 3.09) 8 2.44 (1.06,4.75)
Barrier Jeudi Nov-Jan 740 0 0 (0, 0.50) 0 0* (0,0.51)
Barrier Jeudi Feb-April 902 0 0 (0, 0.40) 2 0.22 (0.03,0.80)
Leogane Aug-Oct 2033 1 0.05 (0, 0.27) 18 0.89 (0.53,1.40)
Leogane Nov-Jan 1385 3 0.22 (0.04, 0.63) 10 0.72 (1.00,2.40)
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the parasite are still under development and testing.
Assessing infection in humans can be considered a "lag-
ging indicator" because the prepatent period may extend
for months after infection. In contrast, entomologic meas-
ures of filarial infection of vectors provide "real-time" esti-
mates of filarial transmission. We compared dissection
and PCR to determine their utility as monitoring tools for
filariasis elimination programs.
For monitoring mosquito infection status within the con-
text of a filariasis elimination program, mosquito dissec-
tion has been the gold standard against which other
methods are compared. Our dissection results show a
marked decrease in infection level from the pre-treatment
period to the end of the post-treatment study period in 3
of the 4 sites that we monitored (Figure 1). The exception
was Mapou, which started and ended the study with
almost the same infection prevalence in the mosquito
populations we collected. This can be attributed to the
smaller than desired sample of mosquitoes captured (379
pre-treatment and 370 during the second post-treatment
time interval) and the low infection prevalence that we
observed there.
Dissection and PCR assays of captured mosquitoes gener-
ated similar, but not identical results. We observed a pos-
itive correlation between larval infection rates determined
by these two methods (Figure 3). The proportion of posi-
tive pools detected by PCR was, as expected, higher than
that obtained by dissection, even after using the PoolS-
creen program to calculate a point estimate of infection
prevalence. This can be accounted for by the increased
sensitivity that is provided by the PCR assay, especially for
detection of early larval stages that are more difficult to
detect by dissection. Independent of the method used,
mass treatment led to a reduction in levels of W. bancrofti
in trapped mosquitoes as assessed by dissection and PCR.
The reductions evident via dissection were observed in all
4 sentinel sites studied, representing an overall decrease of
60.8% from the pre-treatment levels to the final study
interval 6 months post-treatment. The decreases in filaria-
infected mosquitoes were comparable to the decreases in
microfilaria prevalence seen in the human populations in
the sentinel sites.
Although dissection is a very effective way to monitor
infection prevalence in vector populations, it is a very
laborious method for monitoring infection prevalence
that requires highly trained technicians and can be cost
intensive. Dissection is most suitable for monitoring
mosquito infection levels when the infection level in the
mosquito population is greater than 1%. This will be true
in early stages of filariasis programs. The decision to use
dissection rather than PCR may also be influenced by the
trapping method. Household collections may yield sub-
stantially higher rates of infected mosquitoes than the
gravid traps that were employed in our study. When infec-
tion prevalence declines below 1%, the potential for miss-
ing mosquitoes infected with the earliest larval stages and
for misidentifying the species of filarial larvae found
within mosquitoes increases. Another concern pointed
out by Burkot and Ichimori [12] is that, as infection level
declines, increasing numbers of mosquitoes must be dis-
sected in order to demonstrate a significant decline in
infection prevalence. This is especially true for infective
larvae. In our study, the numbers of mosquitoes carrying
infective larvae, as detected by dissection, were insuffi-
cient to allow for an adequate statistical analysis of
Table 4: The Prevalence of W. bancrofti in Mosquito Pools





Aug-Oct 409 96 0.0716 .0451, .0106 1.20 (0.33,3.04)
Masson/ 
Mathieu
Nov-Jan 450 86 0.0161 .0060, .0335 1.34 (0.49, 2.89)
Masson/ 
Mathieu
Feb-April 868 122 0.0171 .0088, .0293 0.14 (0,0.82)
Mapou Aug-Oct 490 77 0.0329 .0175, .0552 0.26 (0.01,1.46)
Mapou Nov-Jan 881 129 0.0104 .0044, .0201 0 (0,0.45)
Mapou Feb-April 507 111 0.0326 .0173, .0547 0.54 (0.07,1.94)
Barrier Jeudi Aug-Oct 456 104 0.0916 .0630, .1269 2.44 (1.06,4.75)
Barrier Jeudi Nov-Jan 693 106 0.0089 * .0030, .0196 0* (0,0.51)
Barrier Jeudi Feb-April 1003 122 0.0226 * .0219, .4722 0.22 (0.03,0.80)
Leogane Aug-Oct 5280 394 0.0441 .0371, .0520 0.89 (0.53,1.40)
Leogane Nov-Jan 1531 184 0.008 * .0039, .0144 0.72 (1.00,2.40)
Leogane Feb-April 1583 173 0.0025 * .0006, .0065 0.75 (0.86,2.42)
* 1Median Pool size = 7; 2Derived with Poolscreen 2.0 software; * Indicates a Significant DifferenceFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/11
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changes in infection prevalence. Monitoring transmission
levels based on levels of infective larvae may not be feasi-
ble within the scope of lymphatic filariasis elimination
programs in settings like Leogane where Culex is the vector
because of the relative rarity of identifying infective mos-
quitoes. Lot quality assurance methods may provide an
alternative sampling strategy that may prove useful for
demonstrating with the smallest possible number of mos-
quitoes that filarial infection is below a pre-established
threshold [13].
PCR assays of mosquitoes permit larger number of sam-
ples to be evaluated for infection prevalence. PCR is both
specific and highly sensitive for the detection of parasite
DNA. The primary limitations are the cost and the need
for a well-equipped lab. In addition, PCR methods are
also limited by a lack of robust statistical methods to com-
pare and analyze data obtained from unequal pool sizes.
Although confidence intervals of infection before and
after treatment were overlapping for 2 of the sentinel sites,
it is important to point out that confidence intervals were
not overlapping for the two locations where dissection
data indicated significant declines in larval prevalence.
We used a competitive PCR system in order to control for
the presence of inhibitors that could prevent amplifica-
tion and detection of parasite DNA. The disadvantage of
the competitive PCR is the need to use an ELISA assay to
quantify the product and the competitor, adding to the
cost of the assay. Work underway is focused on trying to
develop a standardized PCR methodology for all filariasis
programs to employ [14]. Simple standardized methods
Point estimate of W. bancrofti infection prevalence in Leogane Figure 2
Point estimate of W. bancrofti infection prevalence in Leogane. Only pools of 15 mosquitoes were used for this analysis, 
Leogane was the only site with sufficient numbers of pools of this size. The point prevalence for each time interval was esti-
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would permit comparisons of infection levels across epi-
demiologic settings as has been done with PCR assays for
O. volvulus in black flies for Onchocerciasis control pro-
grams [4,5]. PCR methods for onchocerciasis work relia-
bly for pools of up to 100 fly heads, an important
advantage in terms of cost and throughput. As similar
methods are validated for lymphatic filariasis, it is impor-
tant to bear in mind that assay sensitivity will decline as
filarial infection prevalence decreases, independent of the
method used to detect W. bancrofti. Consequently, quality
control considerations will become more important as the
program progresses. WHO should consider distribution
of controls to laboratories involved in PCR testing to per-
mit inter-laboratory comparisons of results. Periodic pro-
ficiency testing represents an additional possibility.
A main concern of mass treatment programs is whether or
not the decreases in transmission will be sustainable over
time and will eliminate completely transmission of
microfilaria to mosquitoes. Although infection levels were
decreased, transmission of W. bancrofti was not inter-
rupted by a single cycle of mass treatment in our study.
This is not surprising given the intensity of transmission
in this setting and the modest coverage in the first round.
Additional follow up will be necessary to determine how
many cycles of mass treatment will be necessary to achieve
interruption of transmission in Leogane. These results will




Scatter plot of W. bancrofti infection prevalence in mosquitoes as determined by dissection and PCR (r = 0.72) Figure 3
Scatter plot of W. bancrofti infection prevalence in mosquitoes as determined by dissection and PCR (r = 0.72). R-value calcu-
lated using Pearson correlation coefficient. Barrier Jeudi is represented with the diamond, Leogane is represented with the 
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